MSS2024
HYBRID

3 - 7 June 2024

PORTOROZ, SLOVENIA

It is our sincere pleasure to invite you to participate in MSS2024. Join us!



Our focus is covering purification solutions from process development to manufacturing, empowered by innovative analytics for emerging gene therapies and vaccines. The symposium will embrace a hybrid format, seamlessly blending in-person interactions with virtual accessibility.

Confirmed speakers

Justina Martinkiene

AstraZeneca, UK

Enabling CIMmultus DEAE columns at scale for plasmid DNA capture

Tjaša Legen

BioNTech, Germany

Manufacturing of mRNA for pre-clinical and clinical studies

Aslan Mehdi Dehghani

Sartorius, USA

Analytical toolbox for reliable characterization of extracellular vesicles

Manfred Reiter

Nuvonis, Austria

The CCX cell line, a novel avian substrate for efficient virus production and seamless (CIM based) virus purification

Zoltán Kis

University of Sheffield, UK

Innovating and digitalising mRNA vaccine and therapeutics production processes

Stefano Menegatti

North Carolina State University, USA

GET+VVIRAL: a purification toolbox for the gene-editing tools and viral vectors

Dan Peer

NeoVac, UK

Next Generation Lipid Nanoparticles for RNA Vaccines and Therapeutics

Chantal Pichon

INSERM, France

Bioproduction of messenger RNA: key benefits and challenges

David Dobnik

National Institute of Biology, Slovenia

New approaches for viral vector genome integrity evaluation

Last chance to get your early tickets
Online registration

You need to complete an online form to register for the conference. Click below to access the form.

Abstract submission

We would like to take this opportunity to invite people from academia and industry to share their knowledge and experience by submitting proposals.

The venue

MSS2024 will be held in Portoroz (Slovenia), a small city on the seaside. You will be able to book a room in different hotels with a special MSS2024 discount.

Previous event highlights

Highlights